Mary Marovich

Immunology and MicrobiologyMedicineBiochemistry, Genetics and Molecular Biology

Pilot corpus only

This score is computed over theSindex pilot corpus and does not cover the full scientific literature. Scores are relative to papers we have ingested — papers, authors, and institutions outside the pilot are not represented. Methodology.

Top 100%percentile

0Author DataRank

Indexed papers

0in pilot corpus

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Papers

Driven by 17 papers. Top paper: “Subcutaneous REGEN-COV Antibody Combination to Prevent Covid-19”.

Subcutaneous REGEN-COV Antibody Combination to Prevent Covid-19

New England Journal of Medicine(2021)10.1056/nejmoa2109682

N/A

9.8DataRank · unranked

480 citations

Eduardo Forleo‐Neto, Bret J. Musser, Flonza Isa, Kuo‐Chen Chan, Neena Sarkar +31 more

Efficacy of the mRNA-1273 SARS-CoV-2 Vaccine at Completion of Blinded Phase

New England Journal of Medicine(2021)10.1056/nejmoa2113017

N/A

8.3DataRank · unranked

662 citations

Lindsey R. Baden, Brandon Essink, Susanne Doblecki‐Lewis, Judith M. Martin, Evan J. Anderson +33 more

Final Analysis of Efficacy and Safety of Single-Dose Ad26.COV2.S

New England Journal of Medicine(2022)10.1056/nejmoa2117608

N/A

4.6DataRank · unranked

251 citations

Glenda Gray, An Vandebosch, Vicky Cárdenas, Georgi Shukarev, Beatriz Grinsztejn +24 more

Examining protective effects of SARS-CoV-2 neutralizing antibodies after vaccination or monoclonal antibody administration

Nature Communications(2023)10.1038/s41467-023-39292-w

N/A

1.9DataRank · unranked

44 citations

Meagan P. O’Brien, Jonathan Fintzi, Michael P. Fay, David C. Montefiori, Allyson Mateja +19 more

Efficacy and safety of a single dose of casirivimab and imdevimab for the prevention of COVID-19 over an 8-month period: a randomised, double-blind, placebo-controlled trial

The Lancet Infectious Diseases(2022)10.1016/s1473-3099(22)00416-9

N/A

0.561DataRank · unranked

41 citations

Meagan P. O’Brien, Eduardo Forleo‐Neto, Neena Sarkar, Flonza Isa, Peijie Hou +88 more

1939. Who to Boost When: An Analysis of Dosing Interval and Age on COVID-19 Outcomes in the COVE Trial During the Delta and Omicron Waves

Open Forum Infectious Diseases(2023)10.1093/ofid/ofad500.2470

N/A

0.208DataRank · unranked

3 citations

Xiaowei Wang, Peter B. Gilbert, Lindsey R. Baden, Hana M. El Sahly, Brandon Essink +10 more

Quantifying how single dose Ad26.COV2.S vaccine efficacy depends on Spike sequence features

Research Square(2023)10.21203/rs.3.rs-2743022/v1

N/A

0DataRank · unranked

0 citations

Li Li, Allan C. deCamp, Morgane Rolland, Michal Juraska, Brian D. Williamson +38 more

Examining protective effects of SARS-CoV-2 neutralizing antibodies after vaccination or monoclonal antibody administration

UNC Libraries(2023)10.17615/gg43-ax44

N/A

0DataRank · unranked

0 citations

David Benkeser, Baden L.R., Holly Janes, David C. Montefiori, Isa F. +19 more

Quantifying how single dose Ad26.COV2.S vaccine efficacy depends on Spike sequence features

Nature Communications(2024)10.1038/s41467-024-46536-w

N/A

0DataRank · unranked

12 citations

Li Li, Allan C. deCamp, Morgane Rolland, Michal Juraska, Brian D. Williamson +45 more

Efficacy and safety of a single dose of casirivimab and imdevimab for the prevention of COVID-19 over an 8-month period: a randomised, double-blind, placebo-controlled trial

UNC Libraries(2025)10.17615/f196-ys27

N/A

0DataRank · unranked

0 citations

Ned Braunstein, K. C. Turner, Neena Sarkar, Myron S. Cohen, Adnan Mahmood +25 more

Rare HIV-1 transmitted/founder lineages identified by deep viral sequencing contribute to rapid shifts in dominant quasispecies during acute and early infection

UNC Libraries(2020)10.17615/fcht-sf53

N/A

0DataRank · unranked

0 citations

Nelson L. Michael, Celina Oropeza, James Arthos, Meera Bose, Sorachai Nitayaphan +35 more

Nasopharyngeal Viral Load Is the Major Driver of Incident Antibody Immune Response to SARS-CoV-2 Infection

UNC Libraries(2025)10.17615/8hrb-tr84

N/A

0DataRank · unranked

0 citations

Gary Herman, Boaz Hirshberg, Bret J. Musser, Andrea T. Hooper, Flonza Isa +8 more

Expansion of Inefficient HIV-Specific CD8 T Cells during Acute Infection

UNC Libraries(2020)10.17615/515q-k747

N/A

0DataRank · unranked

0 citations

Susan M. Johnson, Lucas Maganga, Sodsai Tovanabutra, Michael A. Eller, Morgane Rolland +17 more

The effect of anti-SARS-CoV-2 monoclonal antibody, bamlanivimab, on endogenous immune response to COVID-19 vaccination

medRxiv(2021)10.1101/2021.12.15.21267605

N/A

0DataRank · unranked

6 citations

Jay Tuttle, Lin Zhang, Josh Poorbaugh, Nicole L. Kallewaard, Peter Vaillancourt +11 more

Leveraging lessons learned from the COVID-19 pandemic for HIV

Communications Medicine(2022)10.1038/s43856-022-00175-8

N/A

0DataRank · unranked

5 citations

Tina Tong, Dale J. Hu, Jérôme H. Kim, Karen L. Kotloff, Richard A. Koup +7 more

The anti-SARS-CoV-2 monoclonal antibody, bamlanivimab, minimally impacts the endogenous immune response to COVID-19 vaccination

UNC Libraries(2022)10.17615/77w4-hz26

N/A

0DataRank · unranked

1 citations

Nicole L. Kallewaard, Stephanie Beasley, Montanea Daniels, Joshua J. Freitas, Robert J. Benschop +11 more

Nasopharyngeal Viral Load Is the Major Driver of Incident Antibody Immune Response to SARS-CoV-2 Infection

Open Forum Infectious Diseases(2023)10.1093/ofid/ofad598

N/A

0DataRank · unranked

4 citations

Meagan P. O’Brien, Andrea T. Hooper, Eduardo Forleo‐Neto, Flonza Isa, Peijie Hou +8 more